Schedule 13G ownership disclosure
SILEXION THERAPEUTICS CORP
Ordinary Shares, par value $0.0009 per share · CUSIP: G1281K122
Event date: 2025-03-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- CVI Investments, Inc.
Shares: 456,531 · Class: 4.9%
- Heights Capital Management, Inc.
Shares: 456,531 · Class: 4.9%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001649553-25-000095
- Form type
- SCHEDULE 13G/A
- Filer
- CVI Investments, Inc.
- CIK
- CIK 1649553
- Filed
- May 12, 2025
- Reporting period
- Mar 31, 2025
- Description
- Schedule 13G beneficial ownership